{
    "organizations": [],
    "uuid": "b6cd6eecfb06ad34f6433879703dc9c7d232e17c",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/27/the-associated-press-atara-biotherapeutics-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Atara Biotherapeutics reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $35.3 million in its fourth quarter.\nOn a per-share basis, the South San Francisco, California-based company said it had a loss of $1.15.\nFor the year, the company reported that its loss widened to $119.5 million, or $4 per share.\nAtara Biotherapeutics shares have more than doubled since the beginning of the year. The stock has nearly tripled in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA",
    "published": "2018-02-27T18:17:00.000+02:00",
    "crawled": "2018-02-28T01:28:10.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "south",
        "san",
        "francisco",
        "ap",
        "atara",
        "biotherapeutics",
        "atra",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "south",
        "san",
        "francisco",
        "company",
        "said",
        "loss",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "per",
        "share",
        "atara",
        "biotherapeutics",
        "share",
        "doubled",
        "since",
        "beginning",
        "year",
        "stock",
        "nearly",
        "tripled",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "atra",
        "http"
    ]
}